MANNKIND CORP Increase (Decrease) in Inventories
MANNKIND CORP (MNKD) reported Increase (Decrease) in Inventories of $11.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-05
- MANNKIND CORP increase (decrease) in inventories for the quarter ending 2026-06-30 was -$3.38M, a 180.53% decline year-over-year.
- MANNKIND CORP increase (decrease) in inventories for the quarter ending 2026-03-31 was $14.93M, a 914.13% increase year-over-year.
- MANNKIND CORP increase (decrease) in inventories for the quarter ending 2025-12-31 was -$797.00K, a 125.15% decline year-over-year.
- MANNKIND CORP increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.76M, a 20.13% decline year-over-year.
- MANNKIND CORP increase (decrease) in inventories for fiscal 2025 was $6.62M, a 107.26% increase from fiscal 2024.
- MANNKIND CORP increase (decrease) in inventories for fiscal 2024 was $3.20M, a 71.83% decline from fiscal 2023.
- MANNKIND CORP increase (decrease) in inventories for fiscal 2023 was $11.35M, a 100.12% increase from fiscal 2022.
- MANNKIND CORP increase (decrease) in inventories for fiscal 2022 was $5.67M, a 38.94% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $11.55M 10-Q · filed 2026-08-05 | $10.76M derived: sum of 3 quarters · filed 2026-08-05 | $12.51M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $14.93M 10-Q · filed 2026-05-06 | $14.13M derived: sum of 2 quarters · filed 2026-05-06 | $15.89M derived: sum of 3 quarters · filed 2026-05-06 | $20.08M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | -$797.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $961.00K derived: sum of 2 quarters · filed 2026-02-26 | $5.15M derived: sum of 3 quarters · filed 2026-08-05 | $6.62M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $5.95M derived: sum of 2 quarters · filed 2026-08-05 | $7.42M 10-Q · filed 2025-11-05 | $10.59M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $4.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.66M 10-Q · filed 2026-08-05 | $8.83M derived: sum of 3 quarters · filed 2026-08-05 | $11.03M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $1.47M 10-Q · filed 2026-05-06 | $4.64M derived: sum of 2 quarters · filed 2026-05-06 | $6.84M derived: sum of 3 quarters · filed 2026-05-06 | $5.74M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.37M derived: sum of 2 quarters · filed 2026-02-26 | $4.27M derived: sum of 3 quarters · filed 2026-02-26 | $3.20M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $2.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.10M derived: sum of 2 quarters · filed 2025-11-05 | $27.00K 10-Q · filed 2025-11-05 | $2.37M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.17M 10-Q · filed 2025-08-06 | $169.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.30M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$1.07M 10-Q · filed 2025-05-08 | $1.27M derived: sum of 2 quarters · filed 2026-02-26 | $3.40M derived: sum of 3 quarters · filed 2026-02-26 | $7.63M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.47M derived: sum of 2 quarters · filed 2026-02-26 | $8.71M derived: sum of 3 quarters · filed 2026-02-26 | $11.35M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $6.36M derived: sum of 2 quarters · filed 2024-11-07 | $9.00M 10-Q · filed 2024-11-07 | $13.34M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $4.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $6.88M 10-Q · filed 2024-08-07 | $11.21M derived: sum of 3 quarters · filed 2025-02-26 | $9.83M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $2.64M 10-Q · filed 2024-05-08 | $6.97M derived: sum of 2 quarters · filed 2025-02-26 | $5.59M derived: sum of 3 quarters · filed 2025-02-26 | $7.42M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $4.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.95M derived: sum of 2 quarters · filed 2025-02-26 | $4.78M derived: sum of 3 quarters · filed 2025-02-26 | $5.67M 10-K · filed 2025-02-26 | ||
| 2022-09-30 | -$1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $445.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.34M 10-Q · filed 2023-11-07 | $2.91M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $2.72M 10-Q · filed 2023-08-07 | $4.29M derived: sum of 3 quarters · filed 2024-02-27 | $4.29M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $892.00K 10-Q · filed 2023-05-09 | $2.46M derived: sum of 2 quarters · filed 2024-02-27 | $2.46M derived: sum of 3 quarters · filed 2024-02-27 | $4.90M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.57M derived: sum of 2 quarters · filed 2024-02-27 | $4.00M derived: sum of 3 quarters · filed 2024-02-27 | $4.08M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.43M derived: sum of 2 quarters · filed 2022-11-08 | $2.51M 10-Q · filed 2022-11-08 | $2.60M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-06-30 | $2.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.51M 10-Q · filed 2022-08-09 | $2.60M derived: sum of 3 quarters · filed 2023-02-23 | $3.66M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2021-03-31 | $77.00K 10-Q · filed 2022-05-05 | $169.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.23M derived: sum of 3 quarters · filed 2023-02-23 | $1.82M derived: sum of 4 quarters · filed 2023-02-23 | ||
| 2020-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.15M derived: sum of 2 quarters · filed 2023-02-23 | $1.74M derived: sum of 3 quarters · filed 2023-02-23 | $1.31M 10-K · filed 2023-02-23 | ||
| 2020-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.65M derived: sum of 2 quarters · filed 2021-11-09 | $1.22M 10-Q · filed 2021-11-09 | $1.69M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $592.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $164.00K 10-Q · filed 2021-08-11 | $627.00K derived: sum of 3 quarters · filed 2021-08-11 | $356.00K derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | -$428.00K 10-Q · filed 2021-05-12 | $35.00K derived: sum of 2 quarters · filed 2021-05-12 | -$236.00K derived: sum of 3 quarters · filed 2021-05-12 | $7.00K derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $192.00K derived: sum of 2 quarters · filed 2021-02-25 | $435.00K derived: sum of 3 quarters · filed 2021-02-25 | $558.00K 10-K · filed 2021-02-25 | ||
| 2019-09-30 | -$271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$28.00K derived: sum of 2 quarters · filed 2020-11-04 | $95.00K 10-Q · filed 2020-11-04 | $1.33M derived: sum of 4 quarters · filed 2020-11-04 | ||
| 2019-06-30 | $243.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $366.00K 10-Q · filed 2020-08-05 | $1.60M derived: sum of 3 quarters · filed 2020-08-05 | $1.72M derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $123.00K 10-Q · filed 2020-05-06 | $1.35M derived: sum of 2 quarters · filed 2020-05-06 | $1.48M derived: sum of 3 quarters · filed 2020-05-06 | $1.44M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.35M derived: sum of 2 quarters · filed 2020-02-25 | $1.32M derived: sum of 3 quarters · filed 2020-02-25 | $3.15M 10-K · filed 2020-02-25 | ||
| 2018-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $84.00K derived: sum of 2 quarters · filed 2019-11-08 | $1.92M 10-Q · filed 2019-11-08 | $2.63M derived: sum of 4 quarters · filed 2019-11-08 | ||
| 2018-06-30 | -$38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $1.80M 10-Q · filed 2019-08-07 | $2.50M derived: sum of 3 quarters · filed 2019-08-07 | $2.79M derived: sum of 4 quarters · filed 2019-08-07 | ||
| 2018-03-31 | $1.84M 10-Q · filed 2019-05-07 | $2.54M derived: sum of 2 quarters · filed 2019-05-07 | $2.83M derived: sum of 3 quarters · filed 2019-05-07 | $3.77M derived: sum of 4 quarters · filed 2019-05-07 | ||
| 2017-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $996.00K derived: sum of 2 quarters · filed 2019-02-26 | $1.93M derived: sum of 3 quarters · filed 2019-02-26 | $3.30M 10-K · filed 2019-02-26 | ||
| 2017-09-30 | $290.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.22M derived: sum of 2 quarters · filed 2018-11-01 | $2.59M 10-Q · filed 2018-11-01 | $798.00K 10-Q · filed 2017-11-07 | -$202.00K derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-06-30 | $934.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.30M 10-Q · filed 2018-08-02 | $841.00K 10-Q · filed 2017-08-07 | -$492.00K derived: sum of 3 quarters · filed 2019-02-26 | $1.77M derived: sum of 4 quarters · filed 2019-02-26 | |
| 2017-03-31 | $1.37M 10-Q · filed 2018-05-09 | -$1.43M derived: sum of 2 quarters · filed 2019-02-26 | $832.00K derived: sum of 3 quarters · filed 2019-02-26 | |||
| 2016-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$535.00K derived: sum of 2 quarters · filed 2019-02-26 | $2.33M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $2.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $5.12M 10-Q · filed 2017-11-07 | ||||
| 2016-06-30 | $2.87M 10-Q · filed 2017-08-07 | |||||
| 2015-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $16.29M derived: sum of 2 quarters · filed 2018-02-27 | $19.32M derived: sum of 3 quarters · filed 2018-02-27 | $26.43M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $3.59M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | $6.61M derived: sum of 2 quarters · filed 2016-11-09 | $13.73M 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | $3.03M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | $10.15M 10-Q/A · filed 2016-08-10 | ||||
| 2015-03-31 | $7.12M 10-Q · filed 2016-05-09 | |||||
| 2014-12-31 | $9.67M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |